Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-22.08	-63.13	-51.72
Graham Fair Price	-78.35	2.49	11.49
PEG	13777.09	0.04	< 0.005
Price/Book	33.28	-0.87	-1.30
Price/Cash Flow	913.10	-333.97	32.97
Prices/Earnings	-1493.88	-3.87	-0.24
Price/Sales	1.89	17.78	17.45
Price/FCF	913.10	-333.97	32.97
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-1200.28	-0.30	-0.02
Operating Margin	92.53	-1.17	-15.66
ROA	95.13	-0.06	-1.14
ROE	1.33	0.06	-95.81
ROIC	-13.20	-0.60	95.49
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.05	-0.06	-19.34
Dividends QOQ	-0.36	-0.03	92.30
EBIT QOQ	-6.15	0.95	-84.58
EPS QOQ	-8.33	0.96	-88.51
FCF QOQ	2.10	-1.07	-49.09
Revenue QOQ	-0.41	-0.31	25.41
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	133.76	145.94	9.10
Days Sales Outstanding (DSO)	150.28	147.75	-1.68
Inventory Turnover	0.67	0.62	-8.34
Debt/Capitalization	10.32	11.45	10.89
Quick Ratio	0.10	0.07	-33.91
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	-2.10	-2.22	-5.80
Cash	0.13	0.08	-42.55
Capex	-0.03	< 0.005	81.14
Free Cash Flow	0.08	< 0.005	-93.03
Revenue	0.16	0.11	-30.72
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.26	0.22	-14.58
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-22.49	-34.20	-52.03
Naive Interpretation	Member

06 - Financial Health · Bad

Rating